Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2018 | Cutaneous lymphoma treatment in Spain

Pablo Ortiz Romero • 27 Sep 2018
EORTC CLTF 2018
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases T-Cell Lymphoma

Pablo Ortiz Romero, MD, PhD, of the University Hospital 12 of October, Madrid, Spain, speaks at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, highlighting the current treatment in Spain for early-stage cutaneous T-cell lymphoma patients. Prof. Ortiz reflects on the importance of exposure to sun for mycosis fungoides patients.

More from Pablo Ortiz Romero

1:05
RESMAIN: resmonistat for CTCL maintenance
Pablo Ortiz Romero • 14 Oct 2021
0:58
Approval of brentuximab vedotin for CD30+ mycosis fungoides
Pablo Ortiz Romero • 14 Oct 2021
1:13
Novel therapies on the horizon for CTCL
Pablo Ortiz Romero • 14 Oct 2021
1:23
Pegylated liposomal doxorubicin as maintenance in mycosis fungoides
Pablo Ortiz Romero • 14 Oct 2021

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals